Rua Bioscience Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Rua Bioscience Limited - overview

Established

2017

Location

-, -, New Zealand

Primary Industry

Healthcare

About

Founded in 2017 and based in Gisborne, New Zealand, Rua Bioscience Limited develops and provides medicinal cannabis products. In December 2024, Rua Bioscience Limited raised USD 1. 2 million in venture funding. The firm as of December 2024, is led by its co-founder and Executive Director, Panapa Ehau, and CEO, Paul Naske.


Rua Bioscience specializes in developing and supplying medicinal cannabis products aimed at improving patient health. Their offerings target various medical conditions, serving healthcare providers, pharmacies, and patients. The company cultivates unique cannabis genetics through a focused breeding program, called Plant Discovery and Breeding. Rua Bioscience exports its products to international markets, including Europe and Australia, through strategic partnerships.


The firm revenue generation is structured through direct sales to healthcare providers and partnerships with pharmacies and distributors.   The company plans to utilize the December 2024 funding to cover its business expenses and support cash flow needs.


Primary Industry

Healthcare

Sub Industries

Alternative Medicine, Pharmaceutical Research & Development, Agribusiness

Website

www.ruabio.com

Verticals

Cannabis/Medical Marijuana

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.